The clinical field of interventional cardiology proceeds to progress rapidly. The effectiveness of percutaneous interventions with recent generation drug-eluting stents has progressed a lot over the previous decade. This development in stent performance has expanded the level of evidence towards more complicated interventions such as left main and multi- vessel PCI. Primary improvements continue in the field of medical co-therapy such as antiplatelet therapies (bivalirudin, prasugrel, ticagrelor) and this will further improve outcomes of PCI. Various specific new technologies are poised to enhance the treatment of cardiovascular disease patients and at the same time the safety of the physicians who care for them. These include high res...